Biological Functions of the Low and High Molecular Weight Protein Isoforms of Fibroblast Growth Factor-2 in Cardiovascular Development and Disease

被引:72
|
作者
Liao, Siyun
Bodmer, Janet
Pietras, Daniel
Azhar, Mohamad [2 ,3 ]
Doetschman, Tom [2 ,3 ]
Schultz, Jo El J. [1 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA
[2] Univ Arizona, Inst BIO5, Tucson, AZ USA
[3] Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ USA
关键词
fibroblast growth factor; low and high molecular weight isoforms; ischemia-reperfusion injury; cardiac hypertrophy; vascular biology; cardiovascular development; myocardial development; epicardium; epicardium-derived cells; heart valves; coronary vessels; smooth muscle cells; aortic arch; cardiac fibroblasts; transgenic and knockout mouse models; CARDIAC-SPECIFIC OVEREXPRESSION; THERAPEUTIC ANGIOGENESIS; NUCLEAR-LOCALIZATION; ISCHEMIC-HEART; FACTOR BFGF; CELL-DEATH; HYPERTROPHIC RESPONSE; MYOCARDIAL-INFARCTION; CHROMATIN COMPACTION; NUCLEOTIDE-SEQUENCE;
D O I
10.1002/dvdy.21677
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Fibroblast growth factor 2 (FGF2) consists of multiple protein isoforms (low molecular weight, LAM, and high molecular weight, HAW) produced by alternative translation from the Fgt2 gene. These protein isoforms are localized to different cellular compartments, indicating unique biological activity. FGF2 isoforms in the heart have distinct roles in many pathological circumstances in the heart including cardiac hypertrophy, ischemia-reperfusion injury, and atherosclerosis. These studies suggest distinct biological activities of FGF2 LAM and HMW isoforms both in vitro and in vivo. Yet, due to the limitations that only the recombinant FGF2 LMW isoform is readily available and that the FGF2 antibody is nonspecific with regards to its isoforms, much remains to be determined regarding the role(s) of the FGF2 LMW and HMW isoforms in cellular behavior and in cardiovascular development and pathophysiology. This review summarizes the activities of LMW and HMW isoforms of FGF2 in cardiovascular development and disease. Developmental Dynamics 238:249-264, 2009. (c) 2008 Wiley-Liss, Inc.
引用
收藏
页码:249 / 264
页数:16
相关论文
共 50 条
  • [41] Fibroblast Growth Factor-2 facilitates the growth and chemoresistance of leukemia cells in the bone marrow by modulating osteoblast functions
    Sugimoto, Keiki
    Miyata, Yasuhiko
    Nakayama, Takayuki
    Saito, Shigeki
    Suzuki, Ritsuro
    Hayakawa, Fumihiko
    Nishiwaki, Satoshi
    Mizuno, Hiroki
    Takeshita, Kyosuke
    Kato, Hidefumi
    Ueda, Ryuzo
    Takami, Akiyoshi
    Naoe, Tomoki
    SCIENTIFIC REPORTS, 2016, 6
  • [42] Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease
    Claus, P
    Werner, S
    Timmer, M
    Grothe, C
    NEUROSCIENCE LETTERS, 2004, 360 (03) : 117 - 120
  • [43] The application of genetic mouse models to elucidate a role for fibroblast growth factor-2 in the mammalian cardiovascular system
    Detillieux, KA
    Jimenez, SK
    Sontag, DP
    Kardami, E
    Nickerson, PW
    Cattini, PA
    SIGNAL TRANSDUCTION AND CARDIAC HYPERTROPHY, 2003, 7 : 373 - 391
  • [44] Identification and characterization of an intracellular protein complex that binds fibroblast growth factor-2 in bovine brain
    Chevet, Eric
    Lemaitre, Gilles
    Cailleret, Karine
    Dahan, Sophie
    Bergeron, John J.M.
    Katinka, Michael D.
    Biochemical Journal, 1999, 341 (pt 3): : 713 - 723
  • [45] Synergistic effects of fibroblast growth factor-2 and bone morphogenetic protein-2 on bone induction
    Song, Rongying
    Wang, Dingding
    Zeng, Rong
    Wang, Ju
    MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 4483 - 4492
  • [46] Identification and characterization of an intracellular protein complex that binds fibroblast growth factor-2 in bovine brain
    Chevet, E
    Lemaître, G
    Cailleret, K
    Dahan, S
    Bergeron, JJM
    Katinka, MD
    BIOCHEMICAL JOURNAL, 1999, 341 : 713 - 723
  • [47] Runx2 phosphorylation induced by fibroblast growth factor-2/protein kinase C pathways
    Kim, BG
    Kim, HJ
    Park, HJ
    Kim, YJ
    Yoon, WJ
    Lee, SJ
    Ryoo, HM
    Cho, JY
    PROTEOMICS, 2006, 6 (04) : 1166 - 1174
  • [48] Engineering and expression of a recombinant fusion protein possessing fibroblast growth factor-2 and fibronectin fragment
    Jun-Hyeog Jang
    Chong-Pyoung Chung
    Biotechnology Letters, 2004, 26 : 1837 - 1840
  • [49] Functional comparison of high and low molecular weight basic fibroblast growth factors
    Motozawa, Keiko
    Motoyoshi, Mitsuru
    Saiki, Akari
    Sasaki, Hideto
    Shimizu, Noriyoshi
    Asano, Masatake
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (09) : 7818 - 7826
  • [50] Comparison of protein with DNA therapy for chronic myocardial ischemia using fibroblast growth factor-2
    Heilmann, C
    von Samson, P
    Schlegel, K
    Attmann, T
    von Specht, BU
    Beyersdorf, F
    Lutter, G
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 22 (06) : 957 - 964